232 related articles for article (PubMed ID: 15841624)
1. Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Mallin K; Charles C; Martin LK; Black L; Bryde J
Dermatol Surg; 2005 Mar; 31(3):263-70. PubMed ID: 15841624
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
3. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial.
Baumann L; Slezinger A; Vujevich J; Halem M; Bryde J; Black L; Duncan R
Dermatol Surg; 2003 May; 29(5):508-15. PubMed ID: 12752519
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study.
Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Iyer S
Dermatol Surg; 2002 Sep; 28(9):822-7. PubMed ID: 12269876
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study.
Saadia D; Voustianiouk A; Wang AK; Kaufmann H
Neurology; 2001 Dec; 57(11):2095-9. PubMed ID: 11739832
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study.
Basciani M; Di Rienzo F; Bizzarrini M; Zanchi M; Copetti M; Intiso D
Arch Dermatol Res; 2014 Jul; 306(5):497-503. PubMed ID: 24522897
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
9. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.
Baumann LS; Halem ML
Arch Dermatol; 2003 Feb; 139(2):226-7. PubMed ID: 12588237
[No Abstract] [Full Text] [Related]
10. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
Simonetta Moreau M; Cauhepe C; Magues JP; Senard JM
Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin-B and the management of hyperhidrosis.
Baumann LS; Halem ML
Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
Naumann M; Lowe NJ
BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
[TBL] [Abstract][Full Text] [Related]
14. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
Glogau RG
Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type B (Myobloc).
Baumann L; Black L
Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
[TBL] [Abstract][Full Text] [Related]
16. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients.
Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
J Am Acad Dermatol; 2014 Jun; 70(6):1083-7. PubMed ID: 24630001
[TBL] [Abstract][Full Text] [Related]
17. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
Naumann MK; Hamm H; Lowe NJ;
Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
[TBL] [Abstract][Full Text] [Related]
18. Treatment of overactive bladder with botulinum toxin type B: a pilot study.
Dykstra D; Enriquez A; Valley M
Int Urogynecol J Pelvic Floor Dysfunct; 2003 Dec; 14(6):424-6. PubMed ID: 14677005
[TBL] [Abstract][Full Text] [Related]
19. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
Ondo WG; Hunter C; Moore W
Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
[TBL] [Abstract][Full Text] [Related]
20. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
